An appetite suppressant is anything meant to reduce hunger or help you feel full sooner, but the term covers two very different groups of products. Prescription appetite suppressants such as phentermine, Qsymia, Contrave and the GLP-1 medicines Wegovy and Zepbound went through clinical trials and FDA review before approval. Supplements sold as a natural appetite suppressant, such as glucomannan fiber, saffron extract or probiotic blends, did not need FDA approval before sale, and most of the research behind them is small, short or mixed. This guide explains both groups, what studies found and how to spot weight-loss products with hidden drugs.
Peptide Labs sells some supplements marketed for appetite, and we mention three below. This article is general information, not medical advice.
Key Takeaways
- Prescription appetite suppressants are FDA-approved drugs with defined eligibility, side effects and warnings.
- Phentermine alone is approved only for short-term use; newer options are approved for long-term weight management.
- Supplements marketed for appetite are not FDA-approved, and the human evidence for most of them is limited.
- "GLP-1" supplements contain no GLP-1 medicine.
- The FDA has found hidden drugs such as sibutramine in hundreds of products sold as weight-loss supplements.
What is an appetite suppressant?
Hunger is controlled by signals between the gut and the brain. After a meal, the gut releases hormones such as GLP-1, which act on areas of the brain that regulate appetite and food intake. Several prescription drugs copy these signals, which is why they are described as appetite suppressants. Our explainer on what GLP-1 is covers the hormone in more detail.
“Appetite suppressant” is a description, not a regulatory category. The FDA approves drugs for chronic weight management after reviewing trial data. A dietary supplement may make a structure or function claim, such as “supports appetite control,” but the FDA does not approve that claim in advance, and the label must say the FDA has not evaluated it and that the product is not intended to diagnose or mitigate any disease.
Prescription appetite suppressants approved by the FDA
These medicines need a prescription. Their labels generally limit them to people with obesity, or with overweight plus a weight-related condition, and they are meant to be used with a reduced-calorie diet and more physical activity. We list them for context only; a prescriber decides whether any of them fits.
| Medicine | Type | Approval context | Label notes |
|---|---|---|---|
| Phentermine (several brands) | Stimulant-like appetite suppressant | Approved only as a short-term (a few weeks) add-on to diet, exercise and behavior change | Schedule IV controlled substance |
| Phentermine and topiramate ER (Qsymia) | Combination pill | Approved in 2012 for long-term use; now labeled for adults and children 12 and older | Special safety program because topiramate raises the risk of oral clefts in early pregnancy |
| Naltrexone and bupropion ER (Contrave) | Combination pill | Approved in 2014 for adults | Boxed warning about suicidal thoughts and behaviors |
| Liraglutide (Saxenda), semaglutide (Wegovy), tirzepatide (Zepbound) | GLP-1 based injections | Approved in 2014, 2021 and 2023 | Copy gut hormones that act on appetite areas of the brain |
| Wegovy pill (oral semaglutide), orforglipron (Foundayo) | GLP-1 pills | Approved in December 2025 and April 2026 | Daily tablets; prescription only |
| Setmelanotide (Imcivree) | MC4R agonist injection | Approved in 2020 for certain rare genetic forms of obesity, expanded in 2022 | Only for conditions confirmed by genetic testing or Bardet-Biedl syndrome |
Orlistat works differently. It reduces the amount of fat absorbed from food rather than acting on appetite, and its lower-strength version, alli, is the only weight-loss drug the FDA has approved for sale without a prescription. See our guides to alli (orlistat) and GLP-1 pills.
Natural appetite suppressant supplements: what the evidence shows
Supplements marketed for appetite fall into a few groups. None is FDA-approved for weight loss, and the studies below are the kind of evidence brands cite, with their limits.
Glucomannan and other thickening fibers
Glucomannan is a fiber from the konjac root that absorbs water and swells, which is the reason it is sold for fullness. A 2014 meta-analysis in the Journal of the American College of Nutrition pooled 8 randomized trials and found no statistically significant difference in weight loss between glucomannan and placebo; reported side effects included abdominal discomfort, diarrhea and constipation. NOW Glucomannan capsules carry a label warning that without enough liquid the fiber may swell in the throat and cause choking, and that people who have had esophageal narrowing or swallowing problems should not use it. Our konjac and glucomannan guide has more detail.
Saffron extract
A branded saffron extract called Satiereal was tested in a 2010 study of 60 mildly overweight, healthy women in France. Over 8 weeks, the saffron group recorded fewer snacking episodes in a diary and lost more weight than the placebo group. The study was small, short and relied on self-reported snacking, and it has not been widely repeated. Life Extension Optimized Saffron contains Satiereal extract and no stimulants. Saffron’s safety in pregnancy has not been established. See our saffron supplement guide.
GLP-1 "support" supplements and probiotics
Products labeled GLP-1 support usually combine fiber, probiotics, berberine or plant extracts. They do not contain semaglutide, tirzepatide or any other GLP-1 drug. Pendulum GLP-1 Probiotic, for example, lists three live strains (including Akkermansia muciniphila) with chicory inulin, and the brand states it is not intended for weight loss. Our guide to GLP-1 support supplements explains what these labels mean.
Green tea extract and caffeine
Many appetite and fat-burner formulas add caffeine or green tea extract. A Cochrane review of trials lasting at least 12 weeks found that green tea preparations produced a small, statistically non-significant weight change that was unlikely to be clinically important. Concentrated green tea extracts have been linked to rare cases of liver injury, and the FDA says about 400 mg of caffeine a day is an amount not generally associated with negative effects for most adults, so caffeine from all sources adds up. See our green tea extract guide.
| Ingredient | Why it is marketed for appetite | What studies found | Main caution |
|---|---|---|---|
| Glucomannan | Absorbs water and swells | No significant weight difference vs placebo in pooled trials | Choking risk without enough fluid |
| Saffron extract | Proposed effect on snacking | One small 8-week study with self-reported snacking | Safety in pregnancy not established |
| GLP-1 support blends | Named after the GLP-1 hormone | Few trials of finished products | Contain no GLP-1 medicine |
| Green tea and caffeine | Stimulant effect | Small, non-significant changes in a Cochrane review | Rare liver injury with extracts; caffeine limits |
FDA warnings about tainted weight-loss products
The biggest risk in this category is a product that contains a drug it does not list. The FDA says many products sold as diet pills, fat-burning pills and weight-loss supplements or teas are likely to be contaminated with dangerous hidden ingredients, and that its public list covers only a small fraction of them. A 2018 study in JAMA Network Open reviewed 776 adulterated supplements the FDA identified from 2007 to 2016; 317 were sold for weight loss, and 269 of those contained sibutramine. Others contained phenolphthalein, a former laxative ingredient, or the antidepressant fluoxetine.
Sibutramine was once a prescription appetite suppressant sold as Meridia. It was withdrawn from the U.S. market in October 2010 after a trial of about 10,000 high-risk patients found a 16% increase in serious heart-related events, including heart attacks and strokes. Warning signs the FDA points to include:
- Products advertised as dietary supplements, foods or all-natural alternatives while promising drug-like results.
- Heavy promotion on social media and many glowing reviews.
- Sale online and in stores; being on a store shelf is not proof that a product is safe.
- A product that is not on the FDA list is not proven safe; the list is incomplete.
Who should avoid appetite suppressants or ask first
- Pregnant or breastfeeding people. Qsymia carries a pregnancy warning, the FDA advises asking a doctor about caffeine, and many supplements have not been studied in pregnancy.
- Anyone under 18. Many supplement labels, including the NOW Glucomannan label, are for adults only.
- People with heart conditions or high blood pressure. Phentermine is stimulant-like, and caffeine can raise heart rate.
- People who take medicines, especially antidepressants, diabetes drugs or stimulants. Ask a pharmacist before adding anything.
- People with swallowing problems, who should avoid swelling fibers taken as capsules.
- Anyone with a history of an eating disorder, who should talk to a clinician before trying any product meant to reduce appetite.
You can compare labels in our appetite control category. If you are curious about vinegar, read our review of apple cider vinegar benefits.
Frequently Asked Questions
What is the strongest appetite suppressant?
There is no fair ranking. Prescription drugs such as GLP-1 medicines have the largest trials behind them, but they need a prescription and have side effects. A healthcare provider can say whether any option suits you.
Is there an over-the-counter appetite suppressant approved by the FDA?
No. The only FDA-approved nonprescription weight-loss drug is orlistat (alli), and it works by reducing fat absorption, not appetite. Supplements sold for appetite are not FDA-approved.
What is a natural appetite suppressant?
The phrase usually refers to supplements such as glucomannan, saffron extract, probiotics or green tea. The human evidence for them is limited or mixed, and they are not reviewed by the FDA before sale.
Do GLP-1 supplements work like Ozempic?
No. GLP-1 supplements do not contain semaglutide or any GLP-1 medicine. They usually contain fiber, probiotics or plant extracts, and none is FDA-approved for weight loss.
Is phentermine safe to take long term?
Phentermine alone is approved only for short-term use of a few weeks, and it is a controlled substance. Qsymia combines it with topiramate for longer use. Your prescriber decides what is appropriate.
How can I tell if a weight-loss supplement contains hidden drugs?
You usually cannot tell from the label. Check the FDA’s tainted product notifications, be wary of drug-like promises, and buy from sellers who name the manufacturer.
Questions about a label? Contact us or read our Buyer’s Guide. Follow the label and ask a healthcare provider before starting any supplement, especially if you take medicines. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Last reviewed September 2026.
Related guides: Konjac and Glucomannan: The Plant, the Fiber, Konjac Foods and the Choking Warnings, Saffron Supplement Guide: Extract Types, Standardization and What Studies Measured, What Is GLP-1? The Hormone, How GLP-1 Drugs Work and Every FDA-Approved Option, What Are “GLP-1 Support” Supplements? Reading the Label Honestly, Do Fat Burners Work? Thermogenic Ingredients, Evidence and Risks, Cortisol Belly: Stress, Belly Fat and What Cortisol Supplements Show, 5-HTP: Benefits, Side Effects, Weight Loss Evidence and Drug Interactions, Chromium Picolinate Benefits: What the Evidence Shows for Blood Sugar and Weight, Why Am I Always Hungry? Everyday Reasons and Medical Causes to Rule Out, Hunger Hormones: How Ghrelin, Leptin and Satiety Signals Work, How to Stop Sugar Cravings: Why They Happen and What Research Supports, Phentermine: What It Is, Side Effects and Safety Facts, Contrave: How Naltrexone Bupropion Works, Side Effects and Results, Qsymia (Phentermine-Topiramate): Label Facts, Trials and Safety, Garcinia Cambogia: Does It Work? Evidence, Side Effects and Liver Risks, Bitter Orange (Citrus Aurantium): Evidence, Side Effects and Label Checks.






